Highlights Sinovac Biotech Ltd.

Equities

SVA

AGP8696W1045

Market Closed - Nasdaq Other stock markets 04:00:00 2019-02-22 pm EST			5-day change	1st Jan Change
6.47 ^USD	-0.31%		-.--%	-.--%

Apr. 29	Sinovac Biotech Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Jan. 18	Alternative Liquidity Index LP, a fund managed by Alternative Liquidity Capital cancelled the acquisition of 10.04% stake in Sinovac Biotech Ltd.	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sinovac Biotech Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 29	CI
Alternative Liquidity Index LP, a fund managed by Alternative Liquidity Capital cancelled the acquisition of 10.04% stake in Sinovac Biotech Ltd.	Jan. 17	CI
Sinovac Biotech Ltd. Reports on the Clinical Trial Progress of Its Anti-Covid-19 Antibody Sa55 Injection	23-09-11	CI
Alternative Liquidity Index LP, a fund managed by Alternative Liquidity Capital made an offer to acquire 10.04% stake in Sinovac Biotech Ltd. for an offer per share of $0.03.	23-08-24	CI
Sinovac Biotech Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-15	CI
Sinovac Biotech Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-01	CI
Sinovac Biotech Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-12-29	CI
Sinovac Biotech Says World Health Organization Approved Varicella Vaccine	22-11-04	MT
Sinovac Varicella Vaccine Prequalified by WHO	22-11-03	CI
Sinovac Biotech Gets Chilean Health Regulator Approval to Start Clinical Trial for Its Omicron Containing COVID-19 Vaccine	22-09-06	MT
Sinovac Biotech Ltd. Announces the Chilean Public Health Institute Approve Phase II Clinical Trial for Its Inactivated Omicron Strain	22-09-06	CI
SINOVAC COVID-19 Vaccine Approves for Use in Children Above 6 months of Age in Hong Kong	22-08-03	CI
Sinovac Biotech Ltd. Initiates Clinical Trial for Its Quadrivalent Influenza Vaccine in Chile	22-07-19	CI
Sinovac Biotech Says Brazilian Health Regulator Approves COVID-19 Vaccine for Use in Children Ages 3 to 5	22-07-14	MT
Sinovac Biotech Ltd. Announces its COVID-19 Vaccine Authorized by Brazilian Health Regulatory Agency for Emergency Use in Kids Aged 3-5 in Brazil	22-07-14	CI
Sinovac Biotech Ltd. Joins Hands with University of Hong Kong Clinical Trials Centre Research Team and Gleneagles Hospital Hong Kong to Kick Off A Clinical Trial of an Omicron-Specific Inactivated Vaccine for Booster Use in Hong Kong, China	22-07-04	CI
Sinovac Biotech Secures Conditional Registration in South Africa for COVID-19 Vaccine	22-06-27	MT
Sinovac's COVID-19 vaccine conditionally registered in South Africa	22-06-25	RE
Sinovac Biotech Ltd. Announces South African Health Products Regulatory Authority Granted Conditional Registration to SINOVAC CoronaVac	22-06-25	CI
Sinovac Biotech Ltd. Polio Vaccine Prequalified by WHO	22-06-09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Sinovac Biotech Ltd.

Equities

SVA

AGP8696W1045

Highlights

Filters